Eyegate pharmaceuticals inc (EYEG)
Income statement / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14
Collaboration Revenue

0

-

0

-

0

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration Revenue

-

-

-

3,000

-

-

-

0

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Collaboration Revenue

-

-

-

-

-

-

-

-

-

-

-

-

853

669

0

0

0

-

0

0

-

-

-

-

-

Operating Expenses:
Research and Development

5,605

5,389

5,328

5,182

6,256

8,055

9,695

10,611

11,036

10,330

9,830

9,104

9,323

8,422

7,228

5,187

3,309

2,717

1,442

1,146

634

531

0

0

0

General and Administrative

4,302

4,405

4,339

4,526

4,623

4,441

4,484

4,290

4,301

4,636

4,824

4,987

5,353

5,593

5,601

5,346

4,706

3,960

2,952

2,486

2,057

1,930

0

0

0

Total Operating Expenses

9,908

9,795

9,667

9,708

10,879

12,497

14,180

14,902

15,337

14,966

14,655

14,091

14,677

14,016

12,830

10,533

8,016

6,677

4,394

3,633

2,692

2,462

0

0

0

Operating (Loss) Income Before Other Income, Net

0

-

0

0

0

-

0

0

0

-

0

0

0

-

0

0

-

-

-

-

-

-

-

-

-

Other Income, Net:
Research & development tax credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15

0

0

0

Interest Income

84

108

145

176

162

120

72

18

0

0

0

1

3

3

1

1

1

0

2

2

0

1

0

0

0

Extinguishment of research liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

Change in Fair Value of Warrant Liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-223

-441

-1,323

-1,318

-1,095

0

0

0

Interest Expense

0

0

0

0

0

1

1

1

1

1

1

0

0

0

14

14

14

1,934

2,097

2,267

2,329

441

0

0

0

Other Income, Net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-1

0

0

0

0

0

0

Total Other Income, Net

84

107

145

176

161

119

71

17

-0

-0

-0

0

3

3

-10

-12

-13

-1,710

-1,655

-710

-757

910

0

0

0

Net (Loss) Income

-9,919

-7,096

-6,922

-6,618

-7,561

-10,811

-11,114

-12,130

-12,677

-13,217

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

Net (Loss) Income Per Common Share - Basic

-0.43

-

-

-

0.30

-

-

-

-0.14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net (Loss) Income Per Common Share - Diluted

-0.43

-

-

-

0.19

-

-

-

-0.14

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-Average Shares Outstanding- Basic

4,524

-

-

-

2,917

-

-

-

17,257

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted-Average Shares Outstanding - Diluted

4,524

-

-

-

4,495

-

-

-

17,257

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,343

-12,332

-10,311

-8,029

-8,387

-6,049

-4,344

-3,449

-1,551

0

0

0

Net Loss Attributable to Common Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

Deemed Dividend on Preferred Stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

8,222

0

0

0

-

0

0

0

Net Loss per Common Share - Basic and Diluted

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

59

100

158

222

0

0

0

Net Loss Attributable to Common Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-16,615

-14,341

-12,676

-11,840

-1,773

0

0

0

Net Loss per Common Share- Basic and Diluted

-

-

-1.15

-0.04

-

-

-1.08

-0.07

-

-0.13

-0.24

-0.28

-0.28

-

-0.36

-0.46

-0.31

0.96

-0.19

-0.24

-3.23

-6.50

1.59

-3.82

-0.47

Weighted Average Shares Outstanding- Basic and Diluted

-

-

2,982

43,800

-

-

2,879

37,484

-

17,312

17,204

12,067

10,456

9,844

9,269

8,374

7,846

7,713

7,161

6,363

3,417

-1,633

194

184

2,025

Net (Loss) Income

-9,919

-7,096

-7,518

-6,870

0

-

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-13,343

-12,332

-10,311

-8,029

-8,387

-6,049

-4,344

-3,449

-1,551

0

0

0

Other Comprehensive (Loss) Income:
Foreign Currency Translation Adjustments

5

5

0

4

5

6

10

7

8

7

11

9

6

5

16

8

39

91

0

0

0

-

0

0

0

Comprehensive (Loss) Income

-9,913

-7,091

-6,922

-6,613

-7,556

-10,804

-11,103

-12,123

-12,669

-13,210

-14,076

-13,314

-13,814

-13,338

0

0

0

-

0

0

-

-

0

0

0

Net Loss Attributable to Non-Controlling Interest

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5

59

100

158

222

0

0

0

Other Comprehensive Income Attributable to Non-Controlling Interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-32

0

0

0

-

0

0

0

Comprehensive Income Attributable to Non-Controlling Interests

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-27

0

0

0

-

0

0

0

Comprehensive Loss Attributable to Common Stockholders

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-8,268

0

0

0

-

0

0

0